Tabriz University of Medical Sciences trial of inpatient intravenous urographin plus corticosteroid versus outpatient oral corticosteroid therapy in the Sudden Sensorineural Hearing Loss

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN84083523

Enrollment

Registered

2006-10-13

Start date

2003-01-01

Completion date

Unknown

Last updated

2021-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sudden Sensorineural Hearing Loss Ear, Nose and Throat Sensorineural hearing loss

Interventions

The trial is not a randomised one, as we had two groups: those hospitalised and those managed on outpatient. Hospitalisation was made on the basis of patient's request. Inpatient grou

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged over 12 years 2. A greater than 20 dB hearing loss over at least three frequencies on audiometric testing

Exclusion criteria

Exclusion criteria: 1. General medical condition necessitating a specific therapy 2. Incompliance to the medications

Design outcomes

Primary

Measure	Time frame
Hearing recovery as shown by pure tone average on audiogram.	—

Secondary

Measure	Time frame
No secondary outcome measures	—

Countries

Iran

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026